NCT00247143View on ClinicalTrials.gov

High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease

NAUnknownINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

October 31, 2005

Conditions

HIVAIDS

Interventions

DRUG

Kaletra (drug)

Trial Locations (1)

94121

RECRUITING

San Francisco VA Medical Center, San Francisco

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Abbott

INDUSTRY

lead

Lampiris, Harry W., M.D.

INDIV